Cart
sales@molnova.com
Boc-NH-PEG1-OH
CAS No. 26690-80-2
Boc-NH-PEG1-OH ( —— )
Catalog No. M26918 CAS No. 26690-80-2
Boc-NH-PEG1-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1G | 29 | In Stock |
|
Biological Information
-
Product NameBoc-NH-PEG1-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionBoc-NH-PEG1-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionBoc-NH-PEG1-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCOX; iNOS; TNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26690-80-2
-
Formula Weight161.2
-
Molecular FormulaC7H15NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)NCCO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.á. Río, J. Sanz, et al. Cytotoxic activity of alpha-humulene and trans-caryophyllene from Salvia officinalis in animal and human tumor cells. An. Real Acad. F., 2010, 76(3):343-56.
molnova catalog
related products
-
(-)-Lyoniresinol
(-)-Lyoniresinol has antioxidant activity.
-
BDC2.5 mimotope 1040...
This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.
-
BV02
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
